With sales of $103 million in the fourth quarter and $180 million in its first nine months on the market, Madrigal Pharmaceuticals’ metabolic dysfunction-associated steatohepatitis (MASH ...

Unbought Caymanian writes: It’s official — Cayman’s political merry-go-round has taken yet another spin, and we’re right back where we started. The Progressives (PPM), once seen as a somewhat steady ...